Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information
Descriptionfund sponsor




Omega Funds

Strategically advanced, they enable you to benefit from the expertise of institutional portfolio managers all for a minimum investment of $500! Omega FundsTM give you the opportunity to diversify your investment portfolio and maximize return potential.

Recent Milestones


Company Date Round Size Participants
JenaValve Technology 4/2014Series C$10M10
Visterra 12/2013Series A$8.1M5
Dicerna Pharmaceuticals 7/2013Series C$60M9
JenaValve Technology 7/2013Series C$62.5M8
SpineVision 5/2013Private Equity$10M3
Visterra 11/2012Series A$26.1M5
Egalet 5/2012Series B$14.3M5
Oxagen 11/2009Series C$26.7M9
Elixir Pharmaceuticals 5/2009Series D$12M5
Intarcia Therapeutics 3/2007Series B$50M5
Neurotech 11/2006Series B$35M12
Celletra 3/2005Venture Round$5.7M6



  1. JenaValve Technology Raises Additional $10M in Series C Ventur funing ( [edit]
  2. Visterra Raises $8.1M in Series A Round ( [edit]
  3. Dicerna Pharmaceuticals Raises $60M In Series C Financing ( [edit]
  4. JenaValve Technology Raises $62.5M In Series C Venture Round ( [edit]
  5. SpineVision Raises $10M in Funding ( [edit]
  6. SEC ( [edit]
  7. Denmark's Egalet Grabs $14.3M, New CEO For Abuse-Resistant Drugs ( [edit]
  8. Oxagen rounds up $26.7M in VC ( [edit]
  9. Elixir Pharmaceuticals, Inc.: Series D $12M ( [edit]
  10. Intarcia restarts with $50M for hepatitis, diabetes treatments ( [edit]
  11. Neurotechâ„¢, Inc. Completes $35 Million Private Equity Financing ( [edit]
  12. Celletra raises $5.7m ( [edit]
Edit This Page
Last Edited 4/8/14

Revision History RSS Picture


Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API


Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy